2024Hepatology (baltimore, Md.) : 10.1097/HEP.0000000000001202
Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition
Urbanek-Quaing M, Chou Y, Gupta M, Steppich K, Bremer B, Schmaus H, Deterding K, Maasoumy B, Wedemeyer H, Xu C, Kraft A, Cornberg M
2024Frontiers in Immunology15 : 1459593
Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands
Otten T, Jiang X, Gupta M, Vadaq N, Cleophas-Jacobs M, Dos Santos J, Groenendijk A, Vos W, van Eekeren L, Blaauw M, Meeder E, Richel O, Matzaraki V, van Lunzen J, Joosten L, Li Y, Xu C, van der Ven A, Netea M
2024Pathogens (basel, Switzerland)13 (12) : 1082
Vaccination Schedule and Age Influence Impaired Responsiveness to Hepatitis B Vaccination: A Randomized Trial in Central Asia
Heisig J, Nurmatov Z, Riese P, Trittel S, Sattarova G, Temirbekova S, Zhumagulova G, Nuridinova Z, Derkenbaeva A, Arykbaeva B, Dzhangaziev B, Prokein J, Klopp N, Illig T, Guzmán C, Kasymov O, Akmatov M, Pessler F
2024Plos Pathogens20 (12) : e1012781
Structural characterization of the full-length Hantaan virus polymerase
Keown J, Carrique L, Nilsson-Payant B, Fodor E, Grimes J
2024Science Advances10 (49) : eado2600
Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies
Nagarathinam K, Scheck A, Labuhn M, Ströh L, Herold E, Veselkova B, Tune S, Cramer J, Rosset S, Vollers S, Bankwitz D, Ballmaier M, Böning H, Roth E, Khera T, Ahsendorf-Abidi H, Dittrich-Breiholz O, Obleser J, Nassal M, Jäck H, Pietschmann T, Correia B, Krey T
2024Jhep Reports : Innovation in Hepatology7 (3) : 101293
Monitoring of hepatitis E virus infection and replication by functional tagging of the ORF2 protein
Ankavay M, Da Silva N, Pollán A, Oechslin N, Dinkelborg K, Behrendt P, Moradpour D, Gouttenoire J
2024Virology600 : 110280
MitoTempo treatment as an approach to cure persistent viral infections?
Mischke J, Klein S, Cornberg M, Kraft A
2024The Journal of Infection89 (6) : 106300
Regulation of plasma soluble receptors of TNF and IL-1 in patients with COVID-19 differs from that observed in sepsis
Aksu M, van der Ent T, Zhang Z, Riza A, de Nooijer A, Ricaño-Ponce I, Janssen N, Engel J, Streata I, Dijkstra H, Lemmers H, Grondman I, Koeken V, Antoniadou E, Antonakos N, van de Veerdonk F, Li Y, Giamarellos-Bourboulis E, Netea M, Ziogas A
2024Scientific Reports14 (1) : 29013
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infections
Zeuzem A, Kumar S, Oltmanns C, Witte M, Mischke J, Drick N, Fuge J, Pink I, Tauwaldt J, Debarry J, Illig T, Wedemeyer H, Maasoumy B, Li Y, Kraft A, Cornberg M
2024Clinical and Molecular Hepatology : 10.3350/cmh.2024.0587
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
Tiede A, Stockhoff L, Liu Z, Rieland H, Mauz J, Ohlendorf V, Bremer B, Witt J, Kraft A, Cornberg M, Hinrichs J, Meyer B, Wedemeyer H, Xu C, Falk C, Maasoumy B